Drug intelligence / Profile preview

Soline

Development stage
Unknown
Lead developer
Laboratoire Expanscience
Modality
Small Molecules
Administration
Oral
01

Overview

Soline is a name associated with two distinct therapeutic entities identified in clinical and scientific literature. The first, referred to as Fer-01 (Soline®), is an herbal combination product containing extracts of *Salvia divinorum*, *Lycium*, *Chenpi* (*Citrus reticulata*), and *Dihuang* (*Rehmannia glutinosa*). It has been investigated for its antidepressant properties, primarily due to the presence of salvinorin A, a potent and selective kappa-opioid receptor (KOR) agonist found in *Salvia divinorum*. Unlike typical antidepressants that target serotonin or norepinephrine pathways, this formulation modulates mood through opioid signaling. The second entity is a trademarked ingredient composed of sunflower seed oil unsaponifiables (Helianthus annuus), commonly used in dermatological and cosmetic products. This version of Soline exerts anti-inflammatory and skin-barrier-repair effects by activating the peroxisome proliferator-activated receptor alpha (PPAR-alpha), inhibiting the secretion of pro-inflammatory cytokines such as IL-6, TNF-α, IL-17A, and IL-23, and modulating the TGFβ-related signaling pathway. In preclinical models, it has demonstrated potential for alleviating psoriasis-like skin symptoms and keratinocyte hyperproliferation.

Brand names
Soline
Other names
Helianthus annuus seed oil unsaponifiablesSunflower oil unsaponifiables
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Soline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call